These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 17591290)

  • 1. Canine oral melanoma.
    Bergman PJ
    Clin Tech Small Anim Pract; 2007 May; 22(2):55-60. PubMed ID: 17591290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
    MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
    Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma.
    von Euler H; Sadeghi A; Carlsson B; Rivera P; Loskog A; Segall T; Korsgren O; Tötterman TH
    J Immunother; 2008 May; 31(4):377-84. PubMed ID: 18391758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case report: oral malignant melanoma in an 11-month-old Dobermann].
    Ballinari U; Schiller I; Schroff-Ballinari A; Mazzi M
    Schweiz Arch Tierheilkd; 1998; 140(3):110-3. PubMed ID: 9528347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavoltage irradiation.
    Théon AP; Rodriguez C; Madewell BR
    J Am Vet Med Assoc; 1997 Mar; 210(6):778-84. PubMed ID: 9074679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.
    Bergman PJ; Camps-Palau MA; McKnight JA; Leibman NF; Craft DM; Leung C; Liao J; Riviere I; Sadelain M; Hohenhaus AE; Gregor P; Houghton AN; Perales MA; Wolchok JD
    Vaccine; 2006 May; 24(21):4582-5. PubMed ID: 16188351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.
    Bergman PJ; McKnight J; Novosad A; Charney S; Farrelly J; Craft D; Wulderk M; Jeffers Y; Sadelain M; Hohenhaus AE; Segal N; Gregor P; Engelhorn M; Riviere I; Houghton AN; Wolchok JD
    Clin Cancer Res; 2003 Apr; 9(4):1284-90. PubMed ID: 12684396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined use of irradiation and DNA tumor vaccine to treat canine oral malignant melanoma: a pilot study].
    Herzog A; Buchholz J; Ruess-Melzer K; Lang J; Kaser-Hotz B
    Schweiz Arch Tierheilkd; 2013 Feb; 155(2):135-42. PubMed ID: 23385072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral malignant melanoma: a review of the literature.
    Meleti M; Leemans CR; Mooi WJ; Vescovi P; van der Waal I
    Oral Oncol; 2007 Feb; 43(2):116-21. PubMed ID: 16931116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor size and depth in primary malignant melanoma in the oral cavity influences survival.
    Mücke T; Hölzle F; Kesting MR; Loeffelbein DJ; Robitzky LK; Hohlweg-Majert B; Tannapfel A; Wolff KD
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1409-15. PubMed ID: 19531410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical and pathological study on primary oral mucosal malignant melanoma].
    Chen Y; He Z; Wu L
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Feb; 21(1):31-3. PubMed ID: 12674617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation.
    Sánchez J; Ramirez GA; Buendia AJ; Vilafranca M; Martinez CM; Altimira J; Navarro JA
    Vet Pathol; 2007 Sep; 44(5):676-82. PubMed ID: 17846240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs.
    Théon AP; Madewell BR; Harb MF; Dungworth DL
    J Am Vet Med Assoc; 1993 May; 202(9):1469-75. PubMed ID: 8496103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985-1992).
    McNiel EA; Ogilvie GK; Powers BE; Hutchison JM; Salman MD; Withrow SJ
    J Am Vet Med Assoc; 1997 Dec; 211(11):1422-7. PubMed ID: 9394893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma.
    Dow SW; Elmslie RE; Willson AP; Roche L; Gorman C; Potter TA
    J Clin Invest; 1998 Jun; 101(11):2406-14. PubMed ID: 9616212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality treatment including ONCEPT for canine oral melanoma: A retrospective analysis of 131 dogs.
    Turek M; LaDue T; Looper J; Nagata K; Shiomitsu K; Keyerleber M; Buchholz J; Gieger T; Hetzel S
    Vet Radiol Ultrasound; 2020 Jul; 61(4):471-480. PubMed ID: 32323424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification and staging of melanoma.
    Gershenwald JE; Buzaid AC; Ross MI
    Clin Lab Med; 2000 Dec; 20(4):785-815. PubMed ID: 11221515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004).
    Boston SE; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
    J Am Vet Med Assoc; 2006 Jun; 228(12):1905-8. PubMed ID: 16784383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.